ACP
HPTX

Acuta Capital Partners’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Acuta Capital Partners’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-60,462
Closed -$1.45M – 84
2014
Q4 		$1.45M Buy
+60,462
New +$1.36M 0.98% 30

Other funds holding HPTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acuta Capital Partners's HPTX Position: Q1 2015 in Review

Acuta Capital Partners sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q1 2015, closing a stake of 60,462 shares — an estimated $1.45M sold.

Acuta Capital Partners first reported a position in HPTX in Q4 2014 and held it in 1 quarter. The position peaked at $1.45M in Q4 2014. 134 funds tracked by Wall St. Rank hold HPTX as of Q1 2015.

  • Acuta Capital Partners reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Acuta Capital Partners sold 60,462 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q1 2015, an estimated $1.45M.
  • Acuta Capital Partners first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • Acuta Capital Partners's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.45M in Q4 2014.
  • 134 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q1 2015.

Based on Acuta Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.